Literature DB >> 1704365

The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats.

D E Nies1, T J Hemesath, J H Kim, J R Gulcher, K Stefansson.   

Abstract

Hexabrachion (Tenascin) is a large glycoprotein that appears in extracellular matrices as a disulfide-linked multimer. It is synthesized in an ordered fashion at particular sites during development, is made in large amounts by certain tumors, and is found in restricted tissue locations in the adult. In this report, we describe the sequence of a full length cDNA of human hexabrachion. The encoded protein contains a total of 2203 amino acids and is a linear array of discrete reiterated domains. At the 5' end are encoded hydrophobic residues and 8 flanking cysteines predicted to be responsible for assembly of hexabrachion polypeptides into a radially arranged, six-armed complex. Following this region are 14 1/2 contiguous 31-amino acid epidermal growth factor-like repeats that have a unique structure with respect to the known examples of this type of domain. Immediately adjacent to these repeats lie 15 uninterrupted segments of approximately 90 amino acids which are similar to the Type III units found in fibronectin. At the carboxyl terminus of the protein is a 210-amino acid domain that is similar to fibrinogen. The domain structure of this protein is consistent with the potential for interaction with multiple ligands and for roles in cell adhesion and/or signaling.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704365

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Structure of the human hexabrachion (tenascin) gene.

Authors:  J R Gulcher; D E Nies; M J Alexakos; N A Ravikant; M E Sturgill; L S Marton; K Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Expression of tenascin in joint-associated tissues during development and postnatal growth.

Authors:  E J Mackie; S Ramsey
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

3.  A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices.

Authors:  P Sriramarao; M A Bourdon
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

4.  Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer.

Authors:  Akihiko Takeda; Yoshihide Otani; Hiroyoshi Iseki; Hideki Takeuchi; Kimiyasu Aikawa; Satoru Tabuchi; Nozomi Shinozuka; Toshiaki Saeki; Yasushi Okazaki; Isamu Koyama
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

5.  The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation.

Authors:  S Schenk; R Chiquet-Ehrismann; E J Battegay
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

6.  Immunolocalization of tenascin-C in human type II fiber atrophy.

Authors:  B G Schoser; A Faissner; H H Goebel
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

Review 7.  Tenascins, a growing family of extracellular matrix proteins.

Authors:  R Chiquet-Ehrismann
Journal:  Experientia       Date:  1995-09-29

8.  Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.

Authors:  D D Bigner; M Brown; R E Coleman; A H Friedman; H S Friedman; R E McLendon; S H Bigner; X G Zhao; C J Wikstrand; C N Pegram
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  Involvement of large tenascin-C splice variants in breast cancer progression.

Authors:  Takatsugu Tsunoda; Hiroyasu Inada; Ilunga Kalembeyi; Kyoko Imanaka-Yoshida; Mirei Sakakibara; Ray Okada; Koji Katsuta; Teruyo Sakakura; Yuichi Majima; Toshimichi Yoshida
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts.

Authors:  P Tremble; R Chiquet-Ehrismann; Z Werb
Journal:  Mol Biol Cell       Date:  1994-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.